Baxter Recalls All Heparin Sodium Injection

Baxter Healthcare Corporation has voluntarily recalled all of their multi-dose and single-use vials of heparin sodium for injection, and their heparin lock flush solutions. The Baxter lots of Heparin was linked to mix up of factory names in China that prevented proper inspection.

• Public Health Update: Recall of Heparin Sodium for Injection (2/28/2008)
• FDA-483 on Heparin (2/28/08)
• Public Health Advisory (2/11/2008)
• Question and Answers (2/11/2008)
• FDA News (2/11/2008)
• Baxter to Proceed with Recall of Remaining Heparin Sodium Vial Products (2/28/08)
• Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/ml 10 and 30ml Multi-Dose Vials (1/25/2008)
• Transcript of FDA Press Conference on Adverse Events Associated with Baxter Healthcare Corporation’s Multiple-Dose Vials of Injectable Heparin (2/18/2008 and 2/11/2008)

tag: FDA Recall, Missouri Department of Health, heparin, CDC, Baxter, hemodialysis, photopheresis, Baxter of Deerfield, hypersensitivity, corticosteroids, MedWatch, Multiple-dose Vial Heparin, Baxter Healthcare Corporation